Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

European Innovation Council · Running

HyperProbe Transforming brain surgery by advancing functional-guided neuronavigational imaging

Coordinator
Universita Degli Studi Di Firenze, Italy
Runs
1 October 2022 to 30 September 2027
Status
Running
EU funding
€3.4m
Total cost
€3.5m
Partners
9 organisations in 5 countries
Type
European Innovation Council
Grant agreement
101071040

What the project is doing

In the project's own words, from its summary on CORDIS.

In recent years, through the advancement of imaging technologies (such as MRI, PET, CT, among others) clinical localisation of lesions of the central nervous system (CNS) pre-surgery has made possible for neurosurgeons to plan and navigate away from functional brain locations when removing tumours. However, neuronavigation in the surgical management of brain tumours remains a significant challenge, due to the inability to maintain accurate spatial information of lesioned and non-lesioned locations intraoperatively.

To answer this challenge, we have put together a team of engineers, physicists, data scientists and neurosurgeons to develop an innovative, all-optical intraoperative imaging system based on (i) hyperspectral imaging (HSI) for rapid, multi wavelength spectral acquisition, and (ii) artificial intelligence (AI) for image reconstruction and molecular fingerprint recognition. Our intraoperative HSI system (HyperProbe) will (1) map, monitor and quantify biomolecules of interest; (2) be handheld and user-friendly; (3) apply AI-based methods for the reconstruction of spectral images, the analysis of spatio-spectral data and the development and quantification of novel biomarkers.

We will validate the developed capacity in phantoms, in vivo against gold standard modalities in neuronavigational imaging, and finally provide proof-of principle during brain tumour surgery. HyperProbe aims at providing functional and structural information on biomarkers of interest that is currently missing during neuro-oncological interventions.

Topics

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di FirenzeFlorenceItalyCoordinator
Eibir Gemeinnutzige GmbH Zur Forderung Der Erforschung Der Biomedizinischen BildgebungWienAustriaParticipant
Technische Universitaet MuenchenMuenchenGermanyParticipant
Centre National De La Recherche Scientifique CNRSParisFranceThird party
Hospices Civils De LyonLyonFranceParticipant
Universite Lyon 1 Claude BernardVilleurbanne CedexFranceParticipant
Azienda Ospedaliero-Universitaria CareggiFirenzeItalyParticipant
Emoled Societa a Responsabilita LimitataFirenzeItalyParticipant
University College LondonLondonUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI